Streetbeat News

Revenues

SOTK

Sono-Tek received a significant $2.95M order from an existing clean energy customer, marking the third part of an anticipated multi-system program and the largest order in the company's history.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:19 am

SRDX

Surmodics reported its Q3 2024 earnings with an adjusted EPS of $(0.27), beating the estimate of $(0.33). The company also reported sales of $30.341 million, surpassing the expected $30.006 million.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:18 am

PERI

Perion Network has reiterated its full-year 2024 revenue guidance of $490M to $510M, with an estimated $499.88M. The company also expects adjusted EBITDA of $48M to $52M.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:18 am

VRSK

Verisk Analytics has provided its financial guidance for FY24, projecting EPS between $6.30 and $6.60, which is higher than the estimated $6.13. The company also expects revenue to be in the range of $2.84 billion to $2.90 billion, compared to the estimated $2.885 billion.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:17 am

PERI

Perion Network reported Q2 2024 adjusted EPS of $0.26, significantly beating the estimate of $(0.01). Sales also surpassed expectations, coming in at $108.691 million compared to the $106.994 million estimate.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:16 am

VRSK

Verisk Analytics (NASDAQ:VRSK) reported Q2 2024 adjusted EPS of $1.74, beating the estimate of $1.64. However, sales of $717 million missed the $722.401 million estimate. Sales increased by 6.22% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:16 am

FGEN

FibroGen shares are trading lower after the company announced that its two late-stage trials for pamrevlumab in pancreatic cancer did not meet the primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:15 am

ULS

UL Solutions (NYSE:ULS) reported Q2 earnings of $0.44 per share, beating the analyst estimate of $0.39. Sales were $730 million, surpassing the $716.52 million estimate. Both earnings and sales showed year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:14 am

TSLA

Tesla showcased its first Cybertruck with dry cathode 4680 cells, aiming to reduce production costs and achieve profitability by the end of the year. The new cells are expected to significantly cut costs once production begins in Q4.

Portfolio Pulse from Anan Ashraf

July 31, 2024 | 11:14 am

OPCH

Option Care Health has updated its financial guidance for 2024, expecting net revenue of $4.75 billion to $4.85 billion, adjusted EBITDA of $435 million to $450 million, and cash flow from operations of at least $300 million. The effective tax rate and net interest expense remain consistent with previous guidance.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 11:13 am